Nidan Laboratories and Healthcare share price
NSE: NIDANHealthcare Services
Last close ₹12.30down ₹0.35 (2.77%)
Share price at the NSE close on 23 Oct 2026. Previous close ₹12.65.
52-week range of traded prices to 23 Oct 2026
₹11.50Low, 25 Jun 2026₹24.90High, 1 Dec 2025
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price.
- ₹17 Cr
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. The filing of 25 May 2026
- 11.4
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. The filing of 25 May 2026
- 0.2
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it. The filing of 25 May 2026
- 2.2%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026. The filing of 25 May 2026
- 0.16
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day.
- 3,00066.7% delivered
Results
Standalone; ₹ crore, the charts by years to March, the table by half year.Half-yearly results
Half year to Mar 2026, against the half year beforeFiled 25 May
- RevenueRevenue. The pill is the change in revenue against the half year before: this period's figure divided by that one's, less one, in per cent.
- ₹12 Crdown 5.34%
- Net profitNet profit. The pill is the change in net profit against the half year before: this period's figure divided by that one's, less one, in per cent.
- ₹0.07 Crdown 94.96%
- Net marginNet margin. Net profit as a percentage of revenue: how much of each rupee of sales is left after every cost, interest and tax.
- 0.6%
Revenue by year
Peak revenue ₹30 Cr, year to Mar 2022
Net profit by year, a loss in red
- Net profit
- Loss
A loss in 1 of the 5 years shown
| ₹ crore | Sep 2022 | Mar 2023 | Sep 2023 | Mar 2024 | Sep 2024 | Mar 2025Filed 28 May | Sep 2025Filed 10 Nov | Mar 2026Filed 25 May |
|---|---|---|---|---|---|---|---|---|
| Revenue | 14.1 | 10.2 | 11.8 | 12.4 | 10.5 | 14.0 | 13.1 | 12.4 |
| Net profit | 2.3 | 1.2 | 5.2 | −5.2 | 1.1 | 0.9 | 1.4 | 0.1 |
| Net marginNet margin. Net profit as a percentage of revenue: how much of each rupee of sales is left after every cost, interest and tax. | 16.5% | 12.0% | 43.6% | −41.7% | 10.5% | 6.3% | 10.9% | 0.6% |
Standalone. The last eight half years. The latest is shaded.
Business segments
In the year to Mar 2026 the company reports one business segment, Laboratories and Healthcare Segment, which carries all its revenue.
Valuation
Today, against the company's own history. Not shown, EV/EBITDA: a period of the last twelve months does not state its operating profit. Dividend yield is not shown: no dividend in the years on record.PE ratio and valuation history
Price to earningsPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit.
At or below today's level on 43% of 223 trading days over the last year.
LowestHighest
Its median11.7Industry median20.6
Price to bookPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet.
At or below today's level on 0.5% of 223 trading days over the last year.
LowestHighest
Its median0.3Industry median1.6
Where the return came from
Yearly rates to Mar 2026, per-share figures restated for splits and bonuses.
| Over | Return a year | Earnings growth | Change in P/E | Dividend yield |
|---|---|---|---|---|
| 1 year | −23.0% | −23.9% | +1.3% | 0.0% |
| 3 years | −27.8% | – | – | 0.0% |
Return is price growth plus the average dividend yield. Change in P/E is (1 + price growth) / (1 + earnings growth) - 1, so the parts compound rather than add. Earnings growth and the change in P/E are left empty where earnings per share at either end of the window was a loss or is not on record.
Peers and competitors
Healthcare Service Provider, 36 listed companies, priced on 23 Oct 2026. The table lists the 8 companies closest to Nidan Laboratories and Healthcare in market cap. 1 company in the table last traded before then: its row is priced on its last trade.
Where the company sits among the companies nearest its size
| Company | |||||||||
|---|---|---|---|---|---|---|---|---|---|
 Chennai Meenakshi Multispeciality HospitalCMMHOSP | 27 | – | – | 59.1 | +6.5% | – | – | −6.7% | 0.00% |
 Sharma East India Hospitals and ResSHARMEH | 26 | 21.9 | 1.9 | 9.2 | +14.1% | −9.9% | 9.0% | 9.1% | 0.00% |
 Tejnaksh HealthcareTEJNAKSH | 24 | 19.2 | 0.9 | 7.6 | −13.0% | −37.0% | 4.7% | 5.2% | 0.00% |
 Transgene BiotekTRABI | 19 | – | 2.3 | – | −15.0% | – | −17.5% | −2.6% | 0.00% |
 Family Care HospitalsFAMILYCARE | 11 | – | 1.1 | – | −93.9% | – | −73.4% | −27.5% | 0.00% |
 Dolphin Medical ServicesDOLPHMED | 10 | – | 1.0 | – | – | – | – | – | 0.00% |
 Dhanvantri Jeevan RekhaZDHJERK | 10 | – | 0.9 | 5.7 | +49.9% | – | – | 1.9% | 0.00% |
 Looks Health ServicesLOOKS | 8 | 343.4 | 0.6 | 40.6 | −5.1% | −69.0% | 0.2% | 0.2% | 0.00% |
Market cap in ₹ crore. Growth is the last twelve months against the twelve before. A figure is left empty where it would rest on a loss or the company has under a year of results on record. ROE is the shareholders' profit over their net worth. ROCE is profit before interest and tax over the whole group's net worth plus borrowings, as in the figures at the top of the page.
Latest announcements
Routine notices left out.Share news and announcements
Sep 2026
Aug 2026
20 Aug · Board meeting
May 2026
25 May · Management
Nidan Laboratories and Healthcare share price by year
Each calendar year to 2025.Nidan Laboratories and Healthcare share price history
| Year | Close at year end | Change | Highest close | Lowest close |
|---|---|---|---|---|
| 2025 | 18.65 | −35.4% | 29.15 | 16.55 |
| 2024 | 28.85 | −13.4% | 39.15 | 27.05 |
| 2023 | 33.30 | −30.8% | 55.00 | 30.55 |
| 2022 | 48.15 | −6.6% | 72.95 | 31.80 |
| 2021 | 51.55 | – | 117.75 | 47.00 |
₹ per share, adjusted for splits and bonuses since. Change is on the close at the end of the year before. 2021 is from its first session, 12 Nov 2021.
Recent sessions
The last 10 trading days to 23 Oct 2026, as traded on NSE.
| Date | Open | High | Low | Close | Average price | Volume | Delivery |
|---|---|---|---|---|---|---|---|
| 23 Oct 2026 | 12.15 | 12.50 | 12.15 | 12.30 | 12.32 | 3,000 | 66.7% |
| 21 Oct 2026 | 12.90 | 12.90 | 12.65 | 12.65 | 12.78 | 2,000 | 100.0% |
| 19 Oct 2026 | 13.00 | 13.40 | 12.65 | 12.90 | 12.96 | 7,000 | 85.7% |
| 16 Oct 2026 | 13.55 | 13.55 | 13.00 | 13.00 | 13.28 | 2,000 | 50.0% |
| 15 Oct 2026 | 13.00 | 13.40 | 13.00 | 13.40 | 13.20 | 2,000 | 50.0% |
| 13 Oct 2026 | 12.90 | 13.70 | 12.90 | 13.45 | 13.39 | 4,000 | 75.0% |
| 12 Oct 2026 | 13.40 | 13.40 | 13.00 | 13.20 | 13.20 | 2,000 | 100.0% |
| 9 Oct 2026 | 13.45 | 13.45 | 13.25 | 13.25 | 13.40 | 4,000 | 75.0% |
| 8 Oct 2026 | 12.85 | 13.50 | 12.85 | 13.50 | 13.01 | 4,000 | – |
| 7 Oct 2026 | 13.30 | 13.30 | 13.00 | 13.05 | 13.08 | 11,000 | 72.7% |
Prices in ₹ per share as traded, not adjusted.
Company details
- Legal name
- Nidan Laboratories and Healthcare Limited
- NSE symbol
- NIDAN
- ISIN
- INE0J6L01013
- Industry
- Healthcare Services
- Listed
- Nov 2021
- Face value
- ₹10